Normal view MARC view ISBD view

Holland-Frei cancer medicine / editors, Robert C. Bast, Jr. ... [et al.].

Contributor(s): Bast, Robert C., Jr. (Robert Clinton), 1943- [editor.].
Material type: materialTypeLabelBookCall no.: QZ200 .C36 2016Publication: Hoboken, New Jersey : John Wiley & Sons, Inc., 2016Edition: 9th ed.Description: xxix, 1971 p. : col. ill.ISBN: 9781118934692; 1118934695.Other title: Cancer medicine.Subject(s): Neoplasms
Contents:
1. Cardinal manifestations of cancer -- 2. Biological hallmarks of cancer -- Part 2: TUMOR BIOLOGY -- 3. Molecular biology, genomics, proteomics, and mouse models of human cancer -- 4. Oncogenes -- 5. Tumor suppressor genes -- 6. Epigenetic contributions to human cancer -- 7. Cancer genomics and evolution -- 8. Chromosomal aberrations in cancer -- 9. MicroRNA expression in cancer -- 10. Aberrant signaling pathways in cancer -- 11. Differentiation therapy -- 12. Cancer stem cells -- 13. Cancer and cell death -- 14. Cancer cell immortality: targeting telomerase -- 15. Cancer metabolism --
16. Modeling therapy of late or early-stage metastatic disease in mice -- 17. Tumor angiogenesis -- 18. Cancer bioinformatics -- 19. Systems biology and genomics -- 20. Statistical innovations in cancer research -- 21. Biomarker-based clinical trial design in the era of genomic medicine -- 22. Clinical informatics -- Part 4: CARCINOGENESIS -- 23. Chemical carcinogenesis -- 24. Endocrine and genetic bases of hormone-related cancers -- 25. Ionizing radiation -- 26. Ultraviolet radiation carcinogenesis -- 27. Inflammation and cancer -- 28. RNA tumor viruses -- 29. Herpesviruses -- 30. Papillomaviruses and cervical neoplasia --
31. Hepatitis viruses and hepatoma -- 32. Parasites -- 33. The burden of cancer worldwide: current and future perspectives -- 34. Cancer epidemiology -- 35. Behavioral approaches to cancer prevention -- 36. Diet and nutrition in the etiology and prevention of cancer -- 37. Chemoprevention of cancer -- 38. Cancer screening and early detection -- 39. Nexgen pathology: predicting clinical course and targeting disease causation -- 40. Molecular diagnostics in cancer -- 41. Principles of imaging -- 42. Interventional radiology for the cancer patient -- 43. Principles of surgical oncology -- 44. Principles of radiation oncology -- 45. Principles of medical oncology -- 46. Palliative care and pain management -- 47. Principles of psycho-oncology -- 48. Principles of cancer rehabilitation medicine -- 49. Integrative oncology in cancer care -- 50. Health services research --
51. Personalized medicine in oncology drug development -- 52. Preclinical and early clinical development of chemotherapeutic drugs, mechanism-based agents and biologics -- 53. Tumor growth kinetics -- 54. Principles of dose, schedule, and combination therapy -- 55. Pharmacology -- 56. Folate antagonists -- 57. Pyrimidine and purine antimetabolites -- 58. Alkylating agents and platinum antitumor compounds -- 59. DNA topoisomerase targeting drugs -- 60. Agents targeting microtubules and mitotic processes -- 61. Endocrine therapy for hormone receptor-positive breast cancer -- 62. Drug resistance and its clinical circumvention -- 63. Cytokines, interferons, and hematopoietic growth factors -- 64. Monoclonal serotherapy -- 65. Vaccines and immunostimulants --
66. Cell-based cancer immunotherapy -- 67. Cancer immunotherapy -- 68. Cancer gene therapy -- 69. Cancer nanotechnology -- 70. Hematopoietic cell transplantation -- 71. Principles of pediatric oncology -- 72. Cancer and pregnancy -- 73. Cancer and aging -- 74. Disparities in cancer care -- 75. Neoplasms in acquired immunodeficiency syndrome -- 76. Cancer survivorship: new challenge in cancer medicine -- Part 11: DISEASE SITES -- 77. Primary and metastatic neoplasms of the brain in adults --78. Neoplasms of the eye -- 79. Neoplasms of the endocrine glands: pituitary neoplasms -- 80. Neoplasms of the thyroid -- 81. Neoplasms of the adrenal cortex -- 82. Tumors of the diffuse neuroendocrine and gastroenteropancreatic system -- 83. Neoplasms of the head and neck -- 84. Cancer of the lung -- 85. Malignant pleural mesothelioma -- 86. Thymomas and thymic tumors -- 87. Tumors of the heart and great vessels -- 88. Primary germ cell tumors of the thorax -- 89. Neoplasms of the esophagus -- 90. Carcinoma of the stomach -- 91. Primary neoplasms of the liver -- 92. Gallbladder and bile duct cancer -- 93. Neoplasms of the exocrine pancreas -- 94. Neoplasms of the small intestine, vermiform appendix, and peritoneum, and carcinoma of the colon and rectum -- 95. Neoplasms of the anus --
96. Renal cell carcinoma -- 97. Urothelial cancer -- 98. Neoplasms of the prostate -- 99. Tumors of the penis and the urethra -- 100. Testis cancer -- 101. Neoplasms of the vulva and vagina -- 102. Neoplasms of the cervix -- 103. Endometrial cancer -- 104. Epithelial ovarian, fallopian tube, and peritoneal cancer -- 105. Nonepithelial ovarian malignancies -- 106. Molar pregnancy and gestational trophoblastic neoplasia -- 107. Gynecologic sarcomas -- 108. Neoplasms of the breast -- 109. Malignant melanoma -- 110. Other skin cancers -- 111. Bone tumors -- 112. Soft tissue sarcomas -- 113. The myelodysplastic syndrome -- 114. Acute myeloid leukemia in adults: mast cell leukemia and other mast cell neoplasms -- 115. Chronic myeloid leukemia -- 116. Acute lymphoblastic leukemia -- 117. Chronic lymphocytic leukemia -- 118. Hodgkin lymphoma -- 119. Non-Hodgkin's lymphoma -- 120. Mycosis fungoides and Sézary syndrome -- 121. Plasma cell tumors -- 122. Myeloproliferative neoplasms: essential thrombocythemia, primary myelofibrosis, and polycythemia vera -- 123. Neoplasms of unknown primary site -- 124. Anorexia and cachexia -- 125. Antiemetic therapy -- 126. Neurologic complications of cancer -- 127. Dermatologic complications of cancer chemotherapy -- 128. Skeletal complications -- 129. Hematologic complications and blood bank support -- 130. Coagulopathic complications of cancer patients --
131. Urologic complications -- 132. Cardiac complications -- 133. Respiratory complications -- 134. Gastrointestinal and hepatic complications in cancer patients -- 135. Oral complications of cancer and their treatment -- 136. Gonadal complications -- 137. Sexual dysfunction -- 138. Endocrine complications and paraneoplastic syndromes -- 139. Infections in patients with cancer -- 140. Oncologic emergencies -- 141. A vision for twenty-first century healthcare.
List(s) this item appears in: TUMED-New Book 2018-October (Foreign)
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Collection Call number Status Date due Barcode Item holds
Book Book Nongyao Chaiseri Library
General Stacks
General Books QZ200 .C36 2016 (See Similar Items) Available 31379015568026
Total holds: 0

Includes bibliographical references and index.

1. Cardinal manifestations of cancer -- 2. Biological hallmarks of cancer -- Part 2: TUMOR BIOLOGY -- 3. Molecular biology, genomics, proteomics, and mouse models of human cancer -- 4. Oncogenes -- 5. Tumor suppressor genes -- 6. Epigenetic contributions to human cancer -- 7. Cancer genomics and evolution -- 8. Chromosomal aberrations in cancer -- 9. MicroRNA expression in cancer -- 10. Aberrant signaling pathways in cancer -- 11. Differentiation therapy -- 12. Cancer stem cells -- 13. Cancer and cell death -- 14. Cancer cell immortality: targeting telomerase -- 15. Cancer metabolism --

16. Modeling therapy of late or early-stage metastatic disease in mice -- 17. Tumor angiogenesis -- 18. Cancer bioinformatics -- 19. Systems biology and genomics -- 20. Statistical innovations in cancer research -- 21. Biomarker-based clinical trial design in the era of genomic medicine -- 22. Clinical informatics -- Part 4: CARCINOGENESIS -- 23. Chemical carcinogenesis -- 24. Endocrine and genetic bases of hormone-related cancers -- 25. Ionizing radiation -- 26. Ultraviolet radiation carcinogenesis -- 27. Inflammation and cancer -- 28. RNA tumor viruses -- 29. Herpesviruses -- 30. Papillomaviruses and cervical neoplasia --

31. Hepatitis viruses and hepatoma -- 32. Parasites -- 33. The burden of cancer worldwide: current and future perspectives -- 34. Cancer epidemiology -- 35. Behavioral approaches to cancer prevention -- 36. Diet and nutrition in the etiology and prevention of cancer -- 37. Chemoprevention of cancer -- 38. Cancer screening and early detection -- 39. Nexgen pathology: predicting clinical course and targeting disease causation -- 40. Molecular diagnostics in cancer -- 41. Principles of imaging -- 42. Interventional radiology for the cancer patient -- 43. Principles of surgical oncology -- 44. Principles of radiation oncology -- 45. Principles of medical oncology -- 46. Palliative care and pain management -- 47. Principles of psycho-oncology -- 48. Principles of cancer rehabilitation medicine -- 49. Integrative oncology in cancer care -- 50. Health services research --

51. Personalized medicine in oncology drug development -- 52. Preclinical and early clinical development of chemotherapeutic drugs, mechanism-based agents and biologics -- 53. Tumor growth kinetics -- 54. Principles of dose, schedule, and combination therapy -- 55. Pharmacology -- 56. Folate antagonists -- 57. Pyrimidine and purine antimetabolites -- 58. Alkylating agents and platinum antitumor compounds -- 59. DNA topoisomerase targeting drugs -- 60. Agents targeting microtubules and mitotic processes -- 61. Endocrine therapy for hormone receptor-positive breast cancer -- 62. Drug resistance and its clinical circumvention -- 63. Cytokines, interferons, and hematopoietic growth factors -- 64. Monoclonal serotherapy -- 65. Vaccines and immunostimulants --

66. Cell-based cancer immunotherapy -- 67. Cancer immunotherapy -- 68. Cancer gene therapy -- 69. Cancer nanotechnology -- 70. Hematopoietic cell transplantation -- 71. Principles of pediatric oncology -- 72. Cancer and pregnancy -- 73. Cancer and aging -- 74. Disparities in cancer care -- 75. Neoplasms in acquired immunodeficiency syndrome -- 76. Cancer survivorship: new challenge in cancer medicine -- Part 11: DISEASE SITES -- 77. Primary and metastatic neoplasms of the brain in adults --78. Neoplasms of the eye -- 79. Neoplasms of the endocrine glands: pituitary neoplasms -- 80. Neoplasms of the thyroid -- 81. Neoplasms of the adrenal cortex -- 82. Tumors of the diffuse neuroendocrine and gastroenteropancreatic system -- 83. Neoplasms of the head and neck -- 84. Cancer of the lung -- 85. Malignant pleural mesothelioma -- 86. Thymomas and thymic tumors -- 87. Tumors of the heart and great vessels -- 88. Primary germ cell tumors of the thorax -- 89. Neoplasms of the esophagus -- 90. Carcinoma of the stomach -- 91. Primary neoplasms of the liver -- 92. Gallbladder and bile duct cancer -- 93. Neoplasms of the exocrine pancreas -- 94. Neoplasms of the small intestine, vermiform appendix, and peritoneum, and carcinoma of the colon and rectum -- 95. Neoplasms of the anus --

96. Renal cell carcinoma -- 97. Urothelial cancer -- 98. Neoplasms of the prostate -- 99. Tumors of the penis and the urethra -- 100. Testis cancer -- 101. Neoplasms of the vulva and vagina -- 102. Neoplasms of the cervix -- 103. Endometrial cancer -- 104. Epithelial ovarian, fallopian tube, and peritoneal cancer -- 105. Nonepithelial ovarian malignancies -- 106. Molar pregnancy and gestational trophoblastic neoplasia -- 107. Gynecologic sarcomas -- 108. Neoplasms of the breast -- 109. Malignant melanoma -- 110. Other skin cancers -- 111. Bone tumors -- 112. Soft tissue sarcomas -- 113. The myelodysplastic syndrome -- 114. Acute myeloid leukemia in adults: mast cell leukemia and other mast cell neoplasms -- 115. Chronic myeloid leukemia -- 116. Acute lymphoblastic leukemia -- 117. Chronic lymphocytic leukemia -- 118. Hodgkin lymphoma -- 119. Non-Hodgkin's lymphoma -- 120. Mycosis fungoides and Sézary syndrome -- 121. Plasma cell tumors -- 122. Myeloproliferative neoplasms: essential thrombocythemia, primary myelofibrosis, and polycythemia vera -- 123. Neoplasms of unknown primary site -- 124. Anorexia and cachexia -- 125. Antiemetic therapy -- 126. Neurologic complications of cancer -- 127. Dermatologic complications of cancer chemotherapy -- 128. Skeletal complications -- 129. Hematologic complications and blood bank support -- 130. Coagulopathic complications of cancer patients --

131. Urologic complications -- 132. Cardiac complications -- 133. Respiratory complications -- 134. Gastrointestinal and hepatic complications in cancer patients -- 135. Oral complications of cancer and their treatment -- 136. Gonadal complications -- 137. Sexual dysfunction -- 138. Endocrine complications and paraneoplastic syndromes -- 139. Infections in patients with cancer -- 140. Oncologic emergencies -- 141. A vision for twenty-first century healthcare.

There are no comments for this item.

Click on an image to view it in the image viewer

Open Library:

Thammasat University Library
2 Prachan Road, Phranakorn, Bangkok 10200
Tel: 662 613-3544 (Pridi Banomyong Library, Circulation Desk)
Tel: 662 564-4444 ext. 1305 (Puey Ungphakorn Library (Rangsit Campus), Circulation Desk)